Evidence map›Paper›PMID 29543675›Full record

ArticleThe American journal of surgical pathology2018

The Use of Central Pathology Review With Digital Slide Scanning in Advanced-stage Mycosis Fungoides and Sézary Syndrome: A Multi-institutional and International Pathology Study.

Alejandro A Gru, Jinah Kim, Melissa Pulitzer, Joan Guitart, Maxime Battistella, Gary S Wood, Lorenzo Cerroni, Werner Kempf, Rein Willemze, Joya Pawade and 13 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The American journal of surgical pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. What factors guide treatment selection in mycosis fungoides and Sezary syndrome?Hematology. American Society of Hematology. Education Program · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 17 institutions in 5 countries.

Alejandro A GruDepartments of Pathology and Dermatology.
Jinah KimDepartments of Pathology.
Melissa PulitzerDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY.
Joan GuitartDepartment of Dermatology, Northwestern University, Chicago, IL.
Maxime BattistellaDepartment of Pathology, Hospital St Louis, Paris, France.
Gary S WoodDepartment of Dermatology, University of Wisconsin, Madison, WI.
Lorenzo CerroniDepartment of Dermatology, University of Graz, Graz, Austria.
Werner KempfKempf und Pfaltz, Diagnostic Histopathology, Zurich, Switzerland.
Rein WillemzeDepartment of Dermatology, University of Leiden, Leiden, The Netherlands.
Joya PawadeDepartments of Pathology.
Christiane QuerfeldDivision of Dermatology, City of Hope, Duarte.
Andras SchafferDepartment of Pathology, Washington University in St Louis School of Medicine, St Louis, MO.
Laura PincusDepartment of Dermatology, University of California San Francisco, San Francisco, CA.
Michael TetzlaffDepartments of Pathology.
Madeleine DuvicDermatology, MD Anderson Cancer Center, Houston, TX.
Julia ScarisbrickDermatology, University Hospital Birmingham, Birmingham, UK.
Pierluigi PorcuDivision of Hematologic Malignancies and Hematopoietic Stem Cell Transplantation, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.
Aaron R MangoldDepartment of Dermatology, Mayo Clinic, Scottsdale, AZ.
David J DiCaudoDepartment of Dermatology, Mayo Clinic, Scottsdale, AZ.
Michi ShinoharaDepartment of Dermatology, University of Washington, Seattle, WA.
Eric K HongDermatology, Stanford University, Palo Alto.
Bethany HortonPublic Health Sciences, University of Virginia, Charlottesville, VA.
Youn H KimDermatology, Stanford University, Palo Alto.
Mayo Clinic in Arizona · USStanford University · USAdvanced Dermatology · USCity of Hope · USHôpital Saint-Louis · FRLeiden University · NLMemorial Sloan Kettering Cancer Center · USNIHR Surgical Reconstruction and Microbiology Research Centre · GBNorthwestern University · USThe University of Texas MD Anderson Cancer Center · USThomas Jefferson University · USUniversity of California, San Francisco · USUniversity of Graz · ATUniversity of Virginia · USUniversity of Washington · USUniversity of Wisconsin–Madison · USWashington University in St. Louis · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

This pathology PILOT study aims to define the role and feasibility of centralized pathology review in a cohort of 75 patients from different centers in the United States and Europe using digital slide scanning. The pathologic material from 75 patients who had been diagnosed with mycosis fungoides/Sézary syndrome and were clinically staged as IIb or above was retrieved from 11 participating centers. Each pathology reviewer was provided with the pathologic diagnosis (by the referring pathologist), and the following list of histopathologic criteria (presence or absence) from the initial report: epidermotropism, folliculotropism (FT), large cell transformation, syringotropism, and granulomas. Patients with advance stage were selected for this study as this is a population where there is significant variability in the diagnosis of pathologic prognostic and predictive biomarkers. The slides were digitally scanned with an Aperio scanner and consensus review of cases occurred when major or minor discrepancies between the referral diagnosis and central pathology review occurred. Among the 75 cases, 70 (93.3%) had a final consensus diagnosis between the 3 central review pathologists. The overall agreement between the consensus review and the referring pathologist was 60%. The overall agreement was also higher between the reviewers and consensus review, compared with the referring pathologist and consensus. 65.3% of cases had some type of discrepancy (major or minor) between the outside and consensus review. Major discrepancies were seen in 34 of 73 cases (46.6%; 73 cases indicated a yes or no response). Minor discrepancies were seen in 32 of 75 (42.7%) of cases. Most of the major discrepancies were accounted by a difference in interpretation in the presence or absence of large cell transformation or FT. Most minor discrepancies were explained by a different interpretation in the expression of CD30. We found digital slide scanning to be a beneficial, reliable, and practical for a methodical approach to perform central pathology review in the context of a large clinical prospective study.

Indexed as

Biomarkers, TumorBiopsyEuropeFeasibility StudiesHumansImage Interpretation, Computer-AssistedImmunohistochemistryMicroscopyMycosis FungoidesNeoplasm StagingObserver VariationPredictive Value of TestsProspective StudiesReproducibility of ResultsSezary SyndromeSkin NeoplasmsBiomarkers, Tumor

Identifiers

PMID29543675
PMCPMC9477214
OpenAlexW2811374751

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.